Phase I Safety Study of Ranolazine in Pulmonary Arterial Hypertension-Reference-Cited by-同舟云学术

Phase I Safety Study of Ranolazine in Pulmonary Arterial Hypertension

Published:2015-12 Issue:4 Volume:5 Page:691-700
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

Gomberg‐Maitland Mardi¹²,Schilz Robert³,Mediratta Anuj¹,Addetia Karima¹,Coslet Sandra¹,Thomeas Vasiliki¹²,Gillies Hunter⁴,Oudiz Ronald J.⁵

Affiliation:

1. Section of CardiologyDepartment of MedicineUniversity of ChicagoChicagoIllinoisUSA

2. Committee on Clinical Pharmacology and PharmacogenomicsDepartment of MedicineUniversity of ChicagoChicagoIllinoisUSA

3. Division of PulmonaryCritical Care and Sleep MedicineDepartment of MedicineSchool of MedicineCase Western UniversityClevelandOhioUSA

4. Gilead SciencesFoster CityCaliforniaUSA

5. Division of CardiologyLos Angeles Biomedical Research Institute at Harbor‐UCLA Medical CenterTorranceCaliforniaUSA

Funder

University of Chicago

Gilead Sciences

Novartis

Medtronic

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1086/683813

Reference30 articles.

1. Relevant issues in the pathology and pathobiology of pulmonary hypertension;Tuder RM;J Am Coll Cardiol,2013

2. Double‐blind efficacy and safety study of a novel anti‐ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris;Thadani U;Circulation,1994

3. Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine;Belardinelli L;Heart,2006

4. A study of the effects of ranolazine using automated quantitative analysis of serial myocardial perfusion images;Venkataraman R;JACC Cardiovasc Imaging,2009

5. Cardioprotective effects of ranolazine (RS‐43285) in the isolated perfused rabbit heart;Gralinski MR;Cardiovasc Res,1994

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of ranolazine on right ventricular function, fluid dynamics, and metabolism in patients with precapillary pulmonary hypertension: insights from a longitudinal, randomized, double-blinded, placebo controlled, multicenter study;Frontiers in Cardiovascular Medicine;2023-06-13

2. New Drugs and Therapies in Pulmonary Arterial Hypertension;International Journal of Molecular Sciences;2023-03-19

3. Cardiovascular Effects of Ranolazine and the Scope for Translational Research: A Current Review of Literature;Frontiers in Cardiovascular Drug Discovery;2022-11-09

4. Evolving nonvasodilator treatment options for pulmonary arterial hypertension;Current Opinion in Pulmonary Medicine;2022-07-16

5. Mitochondrial Metabolism, Redox, and Calcium Homeostasis in Pulmonary Arterial Hypertension;Biomedicines;2022-02-01